Careful selection of skin lesions that require expert evaluation is important for early skin cancer detection. Yet challenges include lack of cost-effective asymptomatic screening, geographical inequality in access to specialty dermatology, and long wait…
Continue Reading
An AI system that detects potential skin cancer has been conditionally recommended by the National Institute for Health and Care Excellence (NICE) for use in the NHS.
Deep Ensemble for Recognition of Malignancy (DERM), developed…
What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, today announced the launch of PathAssist Derm, an innovative tool designed to streamline the analysis of skin lesions.
– Available now on the AISight®…
Continue Reading
DigitalHealth.London Accelerator alumnus company, Skin Analytics, has been awarded £2,157,038 by the NHS Cancer Programme – supported by SBRI Healthcare and the Accelerated Access Collaborative – for their Class II UKCA-Certified Artificial Intelligence Medical…
Continue Reading
Teledermatology is playing a key role in the fight against skin cancer, with the NHS recently announcing that it will invest in and accelerate the rollout of it to use within the urgent two-week-wait…
Continue Reading
